Compositions:- Amoxycillin 400 mg + Clavulanic Acid 57 mg Description:- Runmox-457 Dry Syrup is a broad-spectrum paediatric antibiotic formulation containing Amoxycillin and Potassium Clavulanate, designed to provide effective treatment against a wide range of bacterial infections in children. This dual-action combination works synergistically to combat both susceptible and resistant bacteria, ensuring reliable therapeutic outcomes. Amoxycillin is a semi-synthetic penicillin antibiotic that acts by inhibiting the synthesis of the bacterial cell wall, leading to the destruction of bacteria. However, some bacteria produce beta-lactamase enzymes that can inactivate amoxycillin. To overcome this resistance, Potassium Clavulanate is included, which inhibits beta-lactamase enzymes and restores the antibacterial activity of amoxycillin. Each 5 ml of reconstituted oral suspension contains Amoxycillin 400 mg (as Amoxycillin Trihydrate IP) and Clavulanic Acid 57 mg (from Diluted Potassium Clavulanate IP), providing a high-potency formulation suitable for moderate to severe infections. The syrup is prepared in a palatable orange-flavoured suspension base, improving acceptability and compliance in paediatric patients. Runmox-457 Dry Syrup is widely prescribed for the treatment of upper and lower respiratory tract infections, including sinusitis, tonsillitis, pharyngitis, bronchitis, and pneumonia. It is also effective in treating ear infections (otitis media), urinary tract infections, skin and soft tissue infections, and dental infections caused by susceptible organisms. The dry syrup formulation ensures improved stability and shelf life before reconstitution. It is supplied with sterile water for reconstitution and should be shaken well before use to ensure uniform distribution of the active ingredients. The dosage and duration of therapy should be strictly followed as directed by the physician to achieve optimal results and to minimize the risk of antibiotic resistance. Runmox-457 Dry Syrup is intended for paediatric use only and should be administered under the supervision of a registered medical practitioner. As a Schedule H prescription drug, it must not be sold without a valid prescription. Uses:- Runmox-457 Dry Syrup is indicated for the treatment of a wide range of bacterial infections caused by susceptible organisms in paediatric patients, including: *Upper respiratory tract infections such as sinusitis, tonsillitis, pharyngitis *Lower respiratory tract infections including bronchitis and pneumonia *Otitis media (middle ear infections) *Urinary tract infections *Skin and soft tissue infections *Dental infections Other bacterial infections as determined by the physician Storage:- *Store the dry syrup below 25°C, protected from moisture. *After reconstitution, store the suspension as advised by the physician or pharmacist. *Keep the bottle tightly closed after use. *Keep out of reach of children. Conclusion:- Runmox-457 Dry Syrup is a reliable and effective paediatric antibiotic formulation combining Amoxycillin and Potassium Clavulanate to deliver broad-spectrum antibacterial coverage. Its dual-action mechanism helps overcome bacterial resistance while ensuring rapid and sustained therapeutic results. The palatable orange flavour improves acceptance among children, supporting better treatment compliance. When used as prescribed by a registered medical practitioner, Runmox-457 Dry Syrup offers a safe, well-tolerated, and dependable option for the management of a wide range of bacterial infections in paediatric patients.